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Abstract
Background: Humanized mouse models are an increasingly popular preclinical model to study the human
immune response in a biological system. There are a variety of protocols to generate these mice, each differing
in the strain of the recipient, source of hematopoietic stem cells, and mode of transplantation. Though there
is well-documented reconstitution information regarding the spleen, blood, and bone marrow, there is little
information regarding reconstitution of the lymph node and liver. In this report, we sought to compare
reconstitution levels in a variety of immunological tissues, including the lymph node and liver, between mice
engrafted intravenously as adults and intrahepatically in newborns.
Results: CD34+ cells were enriched from cord blood and transplanted intravenously into irradiated adult NOD-Rag1-/-
IL2rγ-/- (NRG) mice or intra-hepatically into irradiated newborn NRG mice. At 9–28 weeks post-engraftment,
immunological tissues were processed and analyzed for human lymphoid and myeloid subsets. Adult and newborn
engrafted humanized mice were comparable in long-term reconstitution of human CD45 cells and subsequent
lymphoid and myeloid subsets in the spleen, bone marrow, thymus, lymph node, and liver. Mice engrafted as
newborns had a higher level of T-cells and a lower level of B-cells compared to mice engrafted as adults. We observed
significant levels of human immune cell engraftment in both the lymph node and the liver, with a predominant
adaptive immune population in both compartments.
Conclusions: Human immune cells repopulate liver and mesenteric lymph nodes of NRG mice and can be used to
study the human immune system in the gastrointestinal tract.
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Key points
 Mice humanized as newborns or adults display
comparable levels of human immune cell
reconstitution
 We observed significant levels of human immune
cell reconstitution in the mesenteric lymph node
and liver
 Each immunological organ has a distinct human
immune profile in the humanized mouse model
 Human NK cells in the livers of humanized mice
display a decreased activation and maturation
phenotype compared to peripheral human NK cells
Background
Although many human pathogens currently under re-
search have been adapted to the mouse model, some are
strictly human pathogens [1]. Further, mice are evolu-
tionarily distinct from humans and are short-lived [1].
Within the last 30 years, however, researchers have been
developing and improving upon a hybrid mouse model
wherein human tissues are housed in the background of
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a mouse. The generation of the humanized mouse model
now allows researchers to directly study the dynamics of
human immune cells in a biological system.
The first humanized mouse models engrafted a human
immune system into SCID mice [1, 2]. Since then, many
protocols have used immunocompromised mice with
varying knockout combinations of NOD, SCID, IL-2R,
Rag1, and Rag2 genes, wherein the complete absence of
all lymphocytes has thus far yielded the best human im-
mune cell engraftment efficiency [1, 2]. Furthermore,
there are a variety of hematopoietic stem cells sources
(HSCs; i.e. peripheral blood, fetal liver, and cord blood)
along with a number of different methods to engraft
those progenitor cells, such as intrahepatically or intra-
peritoneally into newborn mice or intravenously into
adult mice. Each method tends to yield different recon-
stitution rates and immune cell distributions [1, 2]. In
regards to HSCs, progenitor CD34+ cells from cord
either blood or fetal liver are a superior HSC source
compared to PBMCs or bone marrow as there is a
higher level of engraftment and limited development of
graft vs. host disease [3].
A large variety of protocols for generating humanized
mice now exist and encompass an array of murine recip-
ients with different sources of HSCs and the methods of
engraftment. This results in varying reports of human
immune cell engraftment efficiencies and human im-
mune cell subset distribution [1, 2]. In particular, there
is very little data comparing the engraftment of HSCs
into mice as newborns or as adults. Interestingly, Brehm
et al. [4] has shown that mice engrafted as newborn
mice have an overall greater reconstitution of human
CD45+ cells in the blood compared to those engrafted
as adults. Furthermore, newborn engrafted mice had a
greater proportion of T-cells and a lower proportion of
B-cells in the blood compared to mice engrafted as
adults [4]. Unfortunately, the comparison between mice
engrafted as newborns or adults was limited to the blood
and it is unknown whether this trend prevails in all
other immunological organs, including the liver.
Much of the data analyzing human immune cell re-
constitution in mice has been limited to the blood,
spleen, bone marrow, and thymus. Little is know about
human immune cells in lymph nodes or liver. Ishikawa
et al. [5] as well as Traggai et al. [6] both observed mes-
enteric lymph node development in humanized mice
engrafted as newborns, though using different strains of
recipient mice. Traggai et al. [6] further showed that the
mesenteric lymph nodes contained both B and T-cells.
Recently, researchers have developed a new humanized
mouse model in which human liver cells are engrafted
into immunocompromised mice, allowing for the study
of human liver tropic viruses such as hepatitis C virus
and malaria, with the ultimate goal of creating a
humanized mouse model with both human liver and a
human immune system [7–9]. However, the human im-
mune cell composition in the livers of humanized mice
is not well characterized.
In this article, we have conducted a comprehensive
comparative analysis of human immune cell engraftment
and distribution between mice given HSCs as newborn
pubes (1–2 days old) intrahepatically or intravenously as




All animal experiments were approved by the Animal
Research Ethic Board of McMaster University. Use of
human cord blood was approved by the Research Ethic
Board of McMaster University. Human cord blood sam-
ples were obtained with written informed consent from
the mother.
Mice
NRG mice were purchased from the Jackson Lab (Bar
Harbor, ME). The mice were bred and housed under
specific pathogen-free conditions in a level II facility at
the Central Animal Facility at McMaster University.
Mouse colonies were maintained on a 12 h light/12 h
dark cycle.
HSC engraftment into NRG mice
Human umbilical cord blood was collected after delivery
(Department of Obstetrics and Gynecology, McMaster
Children’s Hospital, Hamilton, ON, Canada). Newborn
pups and adults were engrafted as described in [10]. Hu-
man CD34+ HSCs were enriched by negative immuno-
depletion of CD2, CD3, CD14, CD16, CD19, CD24,
CD56, CD66b and glycophorin A cells using a commer-
cially available kit (RosetteSep, StemCell Technologies,
Vancouver, BC, Canada), as per the manufacturer’s in-
structions. This was followed by Lymphoprep density
gradient centrifugation. The isolated cells were cryopre-
served in freezing media containing 90 % FBS and 10 %
DMSO and then stored in liquid nitrogen. Newborn
pups were irradiated using a gamma irradiator (Gamma-
cell 3000) within 72 h of birth with two doses of 9 cGy
separated by 3 h. Immediately after the second dose of
irradiation, 1 × 106 to 2 × 106 thawed HSC cells or
freshly isolated cells were resuspended in 30–40 μl of
Phosphate Buffered Saline (PBS) and injected intrahepa-
tically with a 30 g needle. The pups were then weaned
21 days of age. Adult NRG mice (6–10 weeks old) were
irradiated with a single dose of 550 cGy. Similar to
the pups, approximately 1 × 106 to 2 × 106 cells were
injected immediately following irradiation of the mice
via the lateral tail vein in a total volume of 300 μl
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diluted in PBS by a 30 g needle. All engrafted mice were
facially bled 12 weeks following HSC engraftment.
Twelve weeks following HSC engraftment, blood was
analyzed for the human leukocyte reconstitution by
assessment of human CD45+ cells. Mice with human
CD45 levels greater than 15 % were selected for
experiments.
Isolation of blood, bone marrow, thymus, spleen, liver and
lymph node
Blood samples were taken from the facial vein before
sacrificing the mice and isolation of all other tissues.
The mice were euthanized and single cell suspensions of
the samples were prepared by mechanical crushing,
which was subsequently passed through a 40 μm nylon
mesh cell strainer (BD) to remove aggregates and debris
[10]. The liver cell suspension was subjected to a
LymphoprepTM density gradient for isolation of the
leukocyte population. Red blood cells were removed
using Ammonium-Chloride-Potassium Lysing Buffer
(Life Technologies, Grand Island, NY, USA).
Flow cytometry analysis
Cell suspensions were resuspended in a 0.2 % bovine
serum albumin PBS solution and were blocked with anti
mouse CD16/CD132 antibody (eBiosciences, San Diego,
CA). Samples were stained with the antibody panels
described in Additional file 1: Table S1. Stained cells
were analyzed on a LSR II Flow Cytometry System
(BD Biosciences) and data was analyzed using FlowJo
(Tree Star).
Statistical analysis
Data are presented as average ± SD. Differences between
groups were analyzed by one-way ANOVA and post-hoc
Turkey’s Multiple Comparison Test. A P value <0.05
was considered statistically significant. All calculations
were performed using the GraphPad Prism software
package (Graphpad Software Inc., San Diego, CA).
Results
Intravenous injection in NRG adults and intrahepatic
injection in NRG newborns results in similar levels of
human CD45+ cell reconstitution
We first compared reconstitution of human CD45+ cells
between two different methods of humanized mice gen-
eration: intrahepatic injection into newborn pups or
intravenous injection into adult NRG mice. At 12–28
weeks post engraftment, we observed a similar level of
human immune cell reconstitution in the isolated tissues
between the two methods, with higher levels of reconsti-
tution found in the spleen and bone marrow (Fig. 1a and
Fig. 1 Similar levels of human immune cell reconstitution between NRG mice engrafted intravenously as adults or intrahepatically as pups with
human CD34+ cells. NRG mice were engrafted with human CD34+ cells either intravenously as adults or intrahepatically as newborn pups.
At 22 to 28 weeks after transplantation, spleen, bone marrow, blood and thymuses were taken from the engrafted NRG mice and examined for
human and mouse CD45 expression. Representative flow plots of human and mouse CD45 expression in isolated tissues shown in (a) and (c),
respectively. The percentage of human CD45+ cells in NRG engrafted mice are graphically represented in (b). Percentage of mouse CD45+ cells
in NRG engrafted mice are graphically represented in (d). n = 3; *p < 0.05
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b). We also examined and compared the proportion of
mouse CD45+ cells in the spleen, blood, bone marrow,
and thymus between mice engrafted as adults and
newborn pups. As expected, both groups of humanized
mice had limited expression of mouse CD45+ cells in
the thymus (Fig. 1c and d).
Engraftment of adult NRG mice intravenously showed a
higher proportion of CD19+ B-cells and lower proportion
of CD3+ T-cells in the blood compared to engraftment of
newborns intrahepatically
Though the overall reconstitution of human CD45+ cells
was largely similar between engraftment in adult and
newborn NRG mice, we compared the level of reconsti-
tution of human lymphocytes and myeloid cells between
these two methods (Fig. 2b, c, d, and j). There was no
significant difference in the levels of human CD14+
myeloid cell reconstitution between engraftment as
adults or pups. In the blood, however, humanized mice
engrafted as adults had a significantly increased CD19+
B-cell population and a significantly decreased CD3+ T-
cell population compared to mice engrafted as pups.
When examining the proportion of CD4+ compared to
CD8+ T-cells, both methods of human HSC engraftment
resulted in a significantly higher proportion of CD4+ T-
cells compared to CD8+ T-cells in the spleen, bone mar-
row, blood, and thymus (Fig. 2f ).
Profile of human lymphocyte and myeloid cell
reconstitution is different between immunological tissues
We next examined human lymphocyte and myeloid cell
distribution in the spleen, bone marrow, blood, and thy-
mus of both humanized mice. The human CD3+ T-cell
population constituted nearly 25 % or more of the over-
all human CD45+ cell population in the spleen, blood,
and thymus (Fig. 2a and b). However, we observed a sig-
nificantly decreased proportion of human CD3+ T-cells
in the bone marrow compared to all other tissues ana-
lyzed (3 ± 0.6 %, average ± SD; Fig. 2a and b). In contrast,
the CD19+ B-cell population constituted a significant
proportion of the human CD45+ cells in both the spleen
and bone marrow of mice engrafted as adults and pups,
but only in the blood of mice engrafted as adults (Fig. 2i
and j). As expected, the thymus contained a significantly
decreased level of CD19+ B-cells in comparison to all
other tissues analyzed (4.6 ± 3.7 %; Fig. 2g and h). Upon
examination of human NK (CD56 + CD3-) and NKT-
cells (CD56 + CD3+), we observed a comparable level of
NK cells in all tissues between 1 and 4 %, but very low
levels of NKT cells in the spleen (0.6 ± 0.2 %), bone
marrow (0.4 ± 0.1 %), and blood (0.1 ± 0.01 %; Fig. 2a, c,
and d). Interestingly, the largest proportion of NKT cells
was observed in the thymus of mice engrafted as either
adults or pups (3.3 ± 2.17 %; Fig. 2a and d). In regards to
human CD14+ cell reconstitution, the highest levels
were found in the bone marrow (8.2 ± 1.1 %), compared
to the spleen (0.9 ± 0.2), and thymus (0.2 ± 0.2), but not
blood (3.6 ± 0.7; Fig. 2i and j).
Humanized mice develop mesenteric lymph nodes
comprised of human lymphocytes
There is limited information available on human im-
mune cells in the lymph nodes of humanized mice.
Interestingly, the only lymph nodes found in the recon-
stituted mice were mesenteric lymph nodes. When
comparing human and mouse CD45+ levels in the mes-
enteric lymph nodes of both adult and pup engrafted
humanized mice, we observed a large proportion of hu-
man CD45+ cells compared to few if any mouse CD45+
cells, as expected (Fig. 3a and b). The lymph nodes were
dominated by a CD3+ T-cell compartment, followed by
CD19+ B-cell population (Fig. 3c and d). There were
small proportions of NK and NKT cells present as well
(Fig. 3c and d). Upon further examination of the T-cell
compartment, we observed a higher proportion of CD4+
T-cells compared to CD8+ T-cells, similar to observa-
tions in other tissues examined (Fig. 3e and f).
T- and B-cells dominate the significant human immune
cell reconstitution in the liver of humanized mice
Little is known about human immune cell reconstitution
in the livers of humanized mice. At 9 to 28 weeks post
intravenous or intrahepatic injection, we observed sig-
nificantly higher levels of human CD45+ cells (>75 %)
compared to mouse CD45+ cells (<20 %) in the livers of
both adult and pup engrafted mice (Fig. 4a and b). Upon
further examination of the immune subset composition
of the human CD45+ population, we found that there
were significant CD3+ T-cell and CD19+ B-cells popula-
tions residing in the livers of these humanized mice
(Fig. 4c and d). Moreover, similar to other tissues exam-
ined, we observed a higher proportion of CD4+ T-cells
compared to CD8+ T-cells (Fig. 4e). While T- and B-
cells dominate the immune cell compartment of the
liver, there was a small proportion of CD14+ myeloid
cells and an even smaller level of CD56+ NK cells
(Fig. 4c and d).
Human NK cells display a reduced expression of NKp30
and CD11b within the liver of humanized mice engrafted
as either adults or newborns
Little is known about NK cell phenotype particularly in
liver of humanized mice. There was a significantly de-
creased expression of CD16 on human NK cells in the
bone marrow (6.0 ± 2.4 %) in comparison to the liver
(35.4 ± 10.5), spleen (35.9 ± 6.2), and blood (53.6 ± 5.8),
but not from thymus (17.8 ± 7.6) and lymph node
(23.8 ± 5.9; Fig. 5a). However, when we examined
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NKp30 expression, there was a significant absence of
NKp30 expression on liver NK cells (2.6 ± 1.6) in
comparison to the spleen (81.4 ± 2.6), blood (50.8 ±
3.9), and bone marrow (60 ± 8.3) and a significantly
increased expression of NKp30 on NK cells in the
spleen (Fig. 5d). There was very low, but comparable
expression NKp44, NKp46, NKG2D and CD27 on the
human NK cells between all tissues examined, including
the liver (Fig. 5b, c, and e; NKp46 data not shown). We
observed very little expression of CD57 on the human NK
cells in all three tissues examined (Fig. 5f). Interestingly,
however, there was a significantly higher expression of
Fig. 2 Differences in profile of human lymphoid and myeloid cell reconstitution between spleen, bone marrow, blood, and thymus. At 22 to 28
post-engraftment, spleen, bone marrow, blood, and thymus were isolated, processed, and examined for human CD45, CD3, CD4, CD8, CD56,
CD14, and CD19 expression. All events were first gated on human CD45 expression and subsequently examined for T- and B-cell, NK cell, NKT cell,
and myeloid cell-specific markers. Human CD45+ cells were first examined for CD3 and CD56 expression. Representative flow plots for each tissue
are displayed in (a). Proportions of human CD3+ T-cells stratified by tissue shown in (b). Proportions of human CD3-CD56+ NK cells shown in (c).
Proportions of human CD3 + CD56+ NKT cells graphically shown in (d). Human CD3+ cells were then examined for human CD4+ and CD8+
expression. Representative flow plots shown in (e) and proportions of human CD4+ and CD8+ T-cells within each tissue are shown in (f). Human
CD45+ cells were then examined for CD19+ B-cell expression and CD14+ cell expression. Representative flow plots shown in (g) and (i) for B-cell
expression and myeloid cell expression, respectively, in each tissue and graphically represented in (h) and (j). n = 3; *p < 0.05
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CD11b on human NK cells in the spleen (80.1 ± 2.5) com-
pared to the liver (5.9 ± 1.7) and bone marrow (3.5 ± 1.0;
Fig. 5g).
Discussion
In this study, we compared human immune cell recon-
stitution as well as the distribution of various immune
subsets between two different methods of HSC engraft-
ment: intravenously in adult NRG mice or intrahepati-
cally in newborn NRG mice. Similar to the findings of
Brehm et al. [4], mice engrafted as newborns had higher
levels of human CD3+ T-cells and lower levels of CD19
+ B-cells in the blood compared to mice engrafted as
adults. We observed very little difference in the level of
human CD45+ cells in the blood, spleen, bone marrow,
thymus, lymph node, or liver between mice engrafted as
adults or pups, suggesting that there is very little differ-
ence in human immune cell reconstitution between ei-
ther methods. Furthermore, we observed a long-term
reconstitution (up to 28 weeks) of human immune cells
in mice engrafted as either adults or newborns. Human
T- and B-cell populations were found in all tissues
Fig. 3 T- and B-cells constitute lymph nodes from human immune cell engrafted pups and adults. Lymph nodes were isolated from adult- and
pup-engrafted humanized mice, processed, and examined for mouse CD45 and human CD45, CD3, CD4, CD8, CD56, CD19, and CD14 expression.
Events were first analyzed for mouse and human CD45 expression. Representative flow plots displayed in (a) and graphically represented in (b).
Based on human CD45 expression, lymph nodes were then analyzed for CD3, CD56, CD14, and CD19 expression. Representative flow plots shown
in (c) and stratified by tissue in (d). Human CD3 cells were further examined for human CD4 and CD8 expression, shown in (e) and (f). n = 2
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examined, with lower levels of myeloid, NK, and NKT
cells, similar to the results of others. Lastly, similar to
the human thymus, the humanized mouse thymus con-
tained a high population of human T-cells.
As reported by others, we also observed the develop-
ment of mesenteric lymph nodes in the humanized mice,
engrafted either as adults or pups [5, 6]. Interestingly,
we found that the mesenteric lymph nodes were the only
lymph nodes to develop in the humanized mice. The
presence of microbiota in the gastrointestinal tract likely
facilitates the preferential development of mesenteric
lymph nodes. It has been previously shown, however,
that humanized mice are capable of developing lymph
nodes during infection. Kwant-Mitchell et al. [10] found
that humanized mice in a Rag2-/-γc-/- background that
were immunized or infected with herpes simplex virus
type 2 developed iliac lymph nodes, whereas naïve mice
were only able to develop mesenteric lymph nodes.
Recently, a number of research groups have developed
a humanized mouse model in which human hepatocytes
have been engrafted into mice, thus providing the op-
portunity to study human liver tropic pathogens, such as
hepatitis B and C in a biological system [7]. Further-
more, double-chimeric humanized mice have been de-
veloped, in which both the human immune system and
human liver hepatocytes are engrafted onto a mouse
background, thereby enabling the study of the human
immune response against these pathogens [8, 9]. Human
livers contain a distinct T-cell population in the liver,
with a higher proportion of CD8+ T-cells over CD4+ T-
cells. In our models, we observed a higher ratio of CD4/
CD8+ T-cell population. Similar to all other tissues,
there were very low levels of human NK and myeloid
cells, which has been observed in other studies [7, 11].
Using newborn engraftment, Washburn et al. [7] ob-
served a predominant human T-cell population in the
Fig. 4 Human immune cell reconstitution in the liver of adult and pup-engrafted humanized mice comprised of T- and B-cells. Livers were iso-
lated from humanized mice 9–28 weeks post transplantation and analyzed for mouse CD45 and human CD45, CD3, CD4, CD8, CD56, CD19, CD14
expression. Events were first analyzed for mouse and human CD45 expression. Representative flow plots displayed in (a) and graphically repre-
sented in (b). Based on human CD45 expression, livers were then analyzed for CD3, CD56, CD14, and CD19 expression. Representative flow plots
shown in (c) and stratified by tissue in (d). Human CD3 cells were further examined for human CD4 and CD8 expression, shown in (e) and (f).
n = 3; *p < 0.05
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livers of humanized mice as well as small populations of
NK cells and plasmacytoid dendritic cells. Likewise, Bill-
erbeck et al. [11] observed high levels of human B- and
T-cells in the liver of humanized transgenic A2 mice, in
which mice have been genetically modified to express
HLA-A2. Indeed, the humanized mice we generated
have decreased levels of NK cells, not only in the liver,
but in all other tissues we examined.
The immune population within the human liver is
largely composed of innate immune cells. Approximately
30–50 % of the immune cells in the human liver are NK
cells, which have been observed to express a decreased
level of CD16 compared to peripheral blood NK cells
[12–14]. It is evident that the current humanized mouse
models, in which HSCs are transplanted into immuno-
compromised murine recipients, are unable to support a
identifiable level of human NK cells or other human in-
nate immune cells, likely due to the lack of compatibility
between mouse and human cytokines that are required
to stimulate innate immune cell development [15].
While researchers have attempted to circumvent the
problem by administering specific human cytokines
allowing for innate immune cell development, this re-
sulted in abnormally high levels of human cytokines that
Fig. 5 Differential expression of human CD16, NKp30, and CD11b on NK cells in the liver, spleen, BM, blood thymus and liver of CD34+
hematopoietic stem cell-engrafted pups and adult humanized mice. Liver, spleen, bone marrow, blood, thymus, and lymph node were
isolated from adult- or pup-engrafted humanized mice 22–28 weeks post-engraftment, processed, and examined for a human CD45,
CD3, CD56, CD16, NKp44, NKG2D, NKp30, CD27, CD11b, and CD57. Cells were first gated on human CD45 + cells and subsequently analyzed for
human CD3 and CD56 expression. NK cells (CD3-CD56+) from all isolated tissues were then analyzed for CD16, NKp44, NKG2D, and NKp30 expression in
(a), (b), (c), and (d), respectively. NK cells from liver, spleen, and bone marrow were analyzed for CD27, CD11b, and CD57 expression in (e), (f), and (g),
respectively. n= 5–8; *p< 0.05
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could cause artificial responses [16–19]. Recently, Rong-
vaux et al. [20] developed a transgenic mouse model re-
cipient in which they knocked-in five human cytokines
into the mouse genome, and found that the human cyto-
kines allowed for the greater development of human
monocytes and NK cells in their humanized mouse
model. In particular, the generation of human mono-
cytes were able to trans-present human IL-15 to foster
the development of NK cells [20]. In double-chimeric
mice, the presence of human hepatocytes encouraged
the establishment of human Kupffer cells in the liver,
which are known to trans-present IL-15 and could
stimulate the development of human NK cells [9, 21].
Thus, human hepatocytes may promote a greater level
of human NK cells within the liver of double-chimeric
mice.
Previous studies have found that human NK cells in
these mouse models are not only decreased in number
but are also dysfunctional [22]. We found that human
NK cells within the bone marrow and liver had a re-
duced expression of CD16, NKp30 and CD11b, suggest-
ing that these NK cells are less activated and less
mature. They also displayed a comparable level of CD16
expression to peripheral blood and splenic NK cells. In
contrast, studies examining human liver NK cells found
that they express decreased CD16 compared to periph-
eral blood NK cells [12–14]. Due to the low level of NK
cells, however, it would be beneficial to examine NK cell
phenotype, maturation, and functionality in a model
with a higher frequency of NK cells.
Conclusions
In conclusion, our study reveals that there is little differ-
ence in reconstitution of human immune cells between
mice engrafted as adults or newborns. As well, the com-
prehensive analysis of human immune cell distribution
found that each immunological organ we examined had
a distinct profile of immune cells. More importantly, hu-
man immune cells, particularly NK cells, repopulate the
livers and mesenteric lymph nodes of NRG mice and
this can provide a relevant pre-clinical model to study
the human immune system in the gastrointestinal tract.
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